New evidence confirms link between newer contraceptive pills and higher blood clot risks

Pill-445 
27 May 2015 11:10:49.820

PA 77/15

A study led by academics at The University of Nottingham provides new evidence to confirm the link between newer contraceptive pills and higher risk of serious blood clots (known as venous thromboembolism or VTE).

The results, published today in the BMJ, show that pills containing one of the newer types of progestogen hormone (drospirenone, desogestrel, gestodene, and cyproterone) are associated with an increased risk of VTE than pills containing older progestogens (levonorgestrel and norethisterone).

The researchers, led by Yana Vinogradova, research fellow in Medical Statistics at the University, say this is “an important clarifying study” that “has sufficient power to provide reliable comparative findings for different formulations of combined oral contraceptives.

Click here for full story

Story credits

More information is available from Yana Vinogradova in the School of Medicine, University of Nottingham on +44 (0)115 846 6939, yana.vinogradova@nottingham.ac.uk
  CharlotteAnscombe

Charlotte Anscombe – Media Relations Manager (Arts and Social Sciences)

Email: charlotte.anscombe@nottingham.ac.uk  Phone:+44 (0)115 74 84 417 Location: University Park

Additional resources

No additional resources for this article

Related articles

No related articles

Media Relations - External Relations

The University of Nottingham
YANG Fujia Building
Jubilee Campus
Wollaton Road
Nottingham, NG8 1BB

telephone: +44 (0) 115 951 5798
email: pressoffice@nottingham.ac.uk